Skip to main content
. 2024 Feb 21;14:1322116. doi: 10.3389/fonc.2024.1322116

Figure 5.

Figure 5

Overall survival in advanced BRAF-mutated or BRAF-wild type melanoma patients treated with first-line immunotherapy.